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Motivated by the widespread commercial availability of hy-
brid SPECT/CT and PET/CT imaging and the challenges 
associated with the design and clinical adoption of hybrid 
SPECT/MRI and PET/MRI, we focus, in this special issue 
of BJR, on recent advances and future directions in nucle-
ar medicine physics and instrumentation. During the last 
decade, tremendous efforts focused on addressing the chal-
lenges encountered in the conceptual design of PET/MRI 
systems as well as improving their quantitative performance 
to achieve similar performance compared with standard 
PET/CT systems. With the introduction of solid-state pho-
todetectors, such as avalanche photodiodes (APDs) and 
silicon photomultipliers (SiPMs), the challenges of poten-
tial interference between PET and MRI components have 
now been to some extent sensibly addressed, thus paving 
the way toward compact fully integrated clinical PET/MRI 
systems with time-of-flight (TOF) capability. However, the 
technology is still in an embryonic state and its clinical role 
is yet to be established considering cost/benefit trafeoff. The 
number of scientific papers linked to the above topics has 
been expanding gradually, which spurred the compilation 
of comprehensive reviews in this special issue as a snapshot 
of the enthusiastically changing field of nuclear medicine 
technology.
The first paper in this special issue reviews the physical 
principles, technical developments in instrumentation and 
image reconstruction techniques that enabled the emer-
gence of new clinical applications using SPECT/CT tech-
nology (Ljungberg and Pretorius, doi; http:// dx. doi. org/ 10. 
1259/ bjr. 20160402).1 This is followed by a comprehensive 
overview of the major technical innovations in PET/CT 
systems, focusing primarily on TOF-PET technology, dual-
tracer imaging, inline hadron therapy dose imaging and 
yttrium-90 imaging in the context of resin and glass micro-
sphere liver radioembolizations (Walrand et al, doi; http:// 
dx. doi. org/ 10. 1259/ bjr. 20160534).2 Contrary to PET/CT, 
which was predominately developed since its inception 
for clinical imaging, combined PET/MRI technology 
was initially driven by research in the preclinical field for 
imaging laboratory animals in the mid-1990s. The bulk of 
PET/MR research to date focused on building MR-compat-
ible PET detectors and readout technologies, addressing 
the challenges of MRI-guided PET attenuation correction 
and motion compensation, and also finding a niche or 
primary clinical role for PET/MRI (Cabello and Ziegler; 
doi http:// dx. doi. org/ 10. 1259/ bjr. 20160363).3 Despite the 
widespread interest in PET/MRI instrumentation, systems 
capable of clinical simultaneous SPECT/MRI are not avail-
able yet to date. The challenges and ongoing efforts towards 
designing a dedicated prototype for clinical SPECT/MRI 
are discussed by Hutton et al (doi; http:// dx. doi. org/ 10. 
1259/ bjr. 20160690).4
PET has, since its foundation, established itself as an 
important imaging modality enabling the quantitative 
assessment of molecular targets in vivo. PET quantifica-
tion makes it possible to establish a link between the time-
varying activity concentration in relevant organs/tissues 
and the fundamental parameters standing for the biological 
processes at the cellular level being assessed. The challenges 
associated with fully quantitative PET imaging is addressed 
in a detailed review focusing on recent efforts enabling not 
only to derive conventional PET metrics with higher accu-
racy but also to design novel protocols and data processing 
techniques enabling the generation of whole-body para-
metric images (Zaidi and Karakatsanis, https:// doi. org/ 10. 
1259/ bjr. 20170508).5
There is no shortage of challenges and opportunities 
for the development of innovative nuclear medicine 
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limited space, we were able to give the readers of this issue a 
flavour of recent developments in the field and their poten-
tial applications in clinical and research settings in the future. 
The compilation of this special issue was truthfully gratifying 
and hope that the readers find the contents of value in their 
research.
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